Cryo-Cell International, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

License Agreements

License Agreements	12 Months Ended
Nov. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
License Agreements	NOTE 11 - LICENSE AGREEMENTS The Company has definitive license agreements to market the Company’s umbilical cord blood stem cell programs in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama (“affiliates”). Under the marketing agreements, the Company earns processing and storage revenues from affiliates that store specimens in the Company's facility.

License Agreements

12 Months Ended

Nov. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

NOTE 11 - LICENSE AGREEMENTS

The Company has definitive license agreements to market the Company’s umbilical cord blood stem cell programs in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama (“affiliates”). Under the marketing agreements, the Company earns processing and storage revenues from affiliates that store specimens in the Company's facility.